Literature DB >> 35058589

Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria.

Wenguang Wang1,2,3,4, Haiheng Xu1, Qingsong Ye1, Feng Tao1, Ian Wheeldon5, Ahu Yuan1, Yiqiao Hu6,7, Jinhui Wu8,9,10,11.   

Abstract

Because the tumour microenvironment is typically immunosuppressive, the release of tumour antigens mediated by radiotherapy or chemotherapy does not sufficiently activate immune responses. Here we show that, following radiotherapy, the intratumoural injection of a genetically attenuated strain of Salmonella coated with antigen-adsorbing cationic polymer nanoparticles caused the accumulation of tumour antigens at the tumour's periphery. This enhanced the crosstalk between the antigens and dendritic cells, and resulted in large increases in activated ovalbumin-specific dendritic cells in vitro and in systemic antitumour effects, and extended survival in multiple tumour models in mice, including a model of metastasis and recurrence. The antitumour effects were abrogated by the antibody-mediated depletion of CD8+ T cells, indicating that systemic tumour regression was caused by adaptive immune responses. Leveraging flagellate bacteria to transport tumour antigens to the periphery of tumours to potentiate the activation of dendritic cells may open up new strategies for in situ cancer vaccination.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35058589     DOI: 10.1038/s41551-021-00834-6

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   29.234


  57 in total

Review 1.  Regulatory T cells, tumour immunity and immunotherapy.

Authors:  Weiping Zou
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

2.  Cancer immunotherapy.

Authors:  Marcia McNutt
Journal:  Science       Date:  2013-12-20       Impact factor: 47.728

Review 3.  Dendritic cells in cancer immunology and immunotherapy.

Authors:  Stefanie K Wculek; Francisco J Cueto; Adriana M Mujal; Ignacio Melero; Matthew F Krummel; David Sancho
Journal:  Nat Rev Immunol       Date:  2019-08-29       Impact factor: 53.106

Review 4.  Cancer immunotherapy via dendritic cells.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

Review 5.  Immunotherapy and chemotherapy--a practical partnership.

Authors:  Richard A Lake; Bruce W S Robinson
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

Review 6.  Cancer immunotherapy comes of age.

Authors:  Ira Mellman; George Coukos; Glenn Dranoff
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962

Review 7.  Using immunotherapy to boost the abscopal effect.

Authors:  Wilfred Ngwa; Omoruyi Credit Irabor; Jonathan D Schoenfeld; Jürgen Hesser; Sandra Demaria; Silvia C Formenti
Journal:  Nat Rev Cancer       Date:  2018-02-16       Impact factor: 60.716

Review 8.  Dendritic cells dysfunction in tumour environment.

Authors:  Karim Bennaceur; Jessica Chapman; Leila Brikci-Nigassa; Kamel Sanhadji; Jean-louis Touraine; Jacques Portoukalian
Journal:  Cancer Lett       Date:  2008-06-27       Impact factor: 8.679

9.  Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression.

Authors:  Samir Devalaraja; Tsun Ki Jerrick To; Ian W Folkert; Ramakrishnan Natesan; Md Zahidul Alam; Minghong Li; Yuma Tada; Konstantin Budagyan; Mai T Dang; Li Zhai; Graham P Lobel; Gabrielle E Ciotti; T S Karin Eisinger-Mathason; Irfan A Asangani; Kristy Weber; M Celeste Simon; Malay Haldar
Journal:  Cell       Date:  2020-03-12       Impact factor: 66.850

10.  Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.

Authors:  Yuanzeng Min; Kyle C Roche; Shaomin Tian; Michael J Eblan; Karen P McKinnon; Joseph M Caster; Shengjie Chai; Laura E Herring; Longzhen Zhang; Tian Zhang; Joseph M DeSimone; Joel E Tepper; Benjamin G Vincent; Jonathan S Serody; Andrew Z Wang
Journal:  Nat Nanotechnol       Date:  2017-06-26       Impact factor: 39.213

View more
  3 in total

Review 1.  Current Status and Future Directions of Bacteria-Based Immunotherapy.

Authors:  Quan Tang; Xian Peng; Bo Xu; Xuedong Zhou; Jing Chen; Lei Cheng
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 2.  Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy.

Authors:  Pei Zhou; Yawen Hu; Xiaoyan Wang; Luxuan Shen; Xinghao Liao; Yajuan Zhu; Jiadong Yu; Fulei Zhao; Yi Zhou; Hengshui Shen; Jiong Li
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

3.  Flagellated bacterial porter for in situ tumor vaccine.

Authors:  Haiheng Xu; Yiqiao Hu; Jinhui Wu
Journal:  Microb Cell       Date:  2022-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.